News
Hosted on MSN10mon
Bristol Myers' German Partner Evotec Plans Layoffs, Cites ... - MSNWednesday, Evotec SE (NASDAQ:EVO) reported sales of $201.12 million (182.12 million euros), up from 170.28 million euros reported a year ago. The German drug maker reported an EPS loss of 54 cents ...
Wednesday, Evotec SE (NASDAQ:EVO) reported sales of $201.12 million (182.12 million euros), up from 170.28 million euros reported a year ago. The German drug maker reported an EPS loss of 54 cents ...
Wednesday, Evotec SE (NASDAQ:EVO) reported sales of $201.12 million (182.12 million euros), up from 170.28 million euros reported a year ago. The German drug maker reported an EPS loss of 54 cents ...
Evotec reports a rise in Q2 sales to $201.12M but posts an EPS loss of $0.54. CEO Christian Wojczewski cites market challenges and outlines cost-cutting measures, including a 7% workforce reduction.
Wednesday, Evotec SE (NASDAQ:EVO) reported sales of $201.12 million (182.12 million euros), up from 170.28 million euros reported a year ago. The German drug maker reported an EPS loss of 54 cents ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback